THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Martin B. Leon, MD
New York-Presbyterian/ Columbia University Medical Center
Study Chair - Stephan Baldus, MD
Herzzentrum der Universität zu Köln
Principal Investigator - Torsten P. Vahl, MD
New York-Presbyterian/ Columbia University Medical Center
Principal InvestigatorKOL profile → - Vinod H. Thourani, MD
Piedmont Healthcare
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kerckhoff-Klinik Gmbh Bad Nauheim
Bad Nauheim, Germany
- Herz- Und Diabeteszentrum Nrw Ruhr-Universität Bochum Bad Oeynhausen
Bad Oeynhausen, Germany
- Deutsches Herzzentrum Berlin
Berlin, Germany
- Universitätsklinikum Bonn
Bonn, Germany
- Herzzentrum Der Universität Zu Köln
Cologne, Germany
- Universitätsklinikum Frankfurt
Frankfurt, Germany
- Universitäres Herzzentrum Hamburg
Hamburg, Germany
- Leiden University Medical Center
Leiden, Netherlands
- St. Antonius Hospital
Nieuwegein, Netherlands
- Erasmus University Medical Center
Rotterdam, Netherlands
- Cedars Sinai Medical Center
Los Angeles, California, United States
- California Pacific Medical Center Research Institute
San Francisco, California, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Emory University Hospital
Atlanta, Georgia, United States
- Piedmont Healthcare
Atlanta, Georgia, United States
- University of Michigan
Ann Arbor, Michigan, United States
- New York-Presbyterian/ Columbia University Medical Center
New York, New York, United States
- Baylor Scott & White Research Institute
Dallas, Texas, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Apr 2018
- Primary completion
- 29 Aug 2022
- Completion
- 29 Sept 2027
- Last update posted
- 18 Nov 2022
- Registered enrollment
- 100
- Registry id
- NCT02732704
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.